National Air and Space Museum research and curatorial associate director Jeremy Kinney provided introductory remarks before leading C-SPAN on a tour of the Smithsonian's facility in Washington, D.C.

Author Robert Watson provided a short overview about the Civil War during the summer of 1864 and the near invasion of Washington, D.C., by Confederate forces. The National Civil War Museum in ...

The company is seeing rapid growth in its operations, expanded customer activity, and as a stable financial position heading ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

In the late 2000s, images from rural Bihar of girls in blue uniforms, astride their cycles, triggered a revolution, building ...

The Pensacola News Journal is working with high schools in Escambia and Santa Rosa County to put their top students in the ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2025 with the Securities and Exchange ...

Entered into broad strategic collaboration with Eli Lilly and Company ('Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple ...

Record quarterly revenue of $10.1 million in Q3; a more than 6-fold increase YoY and 60% growth QoQWith a pro-forma cash balance of $840.4 million, we believe Ondas has one of the strongest balance sh ...

New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple Infectious Disease Programs LIKMEZ® (ATI-1501): Building Commercial Momentum in the ...